Acibadem Healthcare Group
BANU ATALAR
Prof. M.D.

BANU ATALAR

Medical Units and Clinical Services
  • Radiation Oncology

Prof. Banu Atalar is a radiation oncology specialist with a strong academic and clinical background. She earned her professorship at Acibadem University in 2018 after serving as an associate professor there since 2013. Her work spans patient care, teaching, and research in therapeutic radiology. She is an active member of several professional organizations, including the Turkish Medical Association, the Turkish Society of Radiation Oncology, ESTRO (European Society for Therapeutic Radiology and Oncology), ASCO (American Society of Clinical Oncology) — where she also contributes as a member of the International Affairs Advisory Group — IASLC (International Association for the Study of Lung Cancer), and the Rare Cancer Network (RCN). These memberships reflect her commitment to international collaboration and advancing care for complex and rare cancers.

Education

  • 2018 Acibadem University / Professorship
  • 2009 Acibadem University / Assistant Professorship
  • 2004 Istanbul University Cerrahpasa Faculty of Medicine Radiation Oncology
  • 1993 – 1999 Istanbul University Istanbul Faculty of Medicine

Experience

  • 2013 Acibadem University / Associate Professorship
  • 2011 Stanford University Department of Radiation Oncology
  • 2009 Acibadem Health Group
  • 2008 – 2009 Göztepe Medical Park Hospital / Radiation Oncology Specialist
  • 2005 – 2008 V.K.V. Italian and American Hospitals / Radiation Oncology Specialist

Memberships

  • Turkish Medical Association
  • Turkish Society of Radiation Oncology
  • European Society for Therapeutic Radiology and Oncology (ESTRO)
  • American Society of Clinical Oncology (ASCO)
  • International Affairs Advisory Group Member (ASCO)
  • IASLC (International Association for the Study of Lung Cancer)
  • RCN (Rare Cancer Network)

Publications

  • Intraoperative Radiotherapy in Recurrent Rectal Cancer
    ACU Health Bil Derg https://doi.org/10.31067/0.2018.88 Bilgin İ.A, Aytaç E, Bayraktar İ.E, Şahin B, Atalar B, Beşe N, Özyar E, Baca B, Hamzaoğlu İ, Karahasanoğlu T.
  • Brachytherapy for Inoperable Cervical Cancer
    Turk J Oncol 2017;32 (Supp1): 101-106 Poyraz D, Aydin G, Atalar B, Ozyar E.
  • .Roboticradiosurgery of head and neck paragangliomas: a single institution experience
    Asia Pac J Clin Oncol. 2017 May 24. Tosun I, Atalar B, Sahin B, Gungor G, Aydin G, Yapici B, Ozyar E.
  • Non-small Cell Lung Cancer with Multiple Brain Metastases Treated with Radiosurgery and Erlotinib: A Case Report
    Cureus. 2017 Dec 29;9(12):e2003. doi:10.7759/cureus.2003 Sahin B, Mustafayev T, Aydin G, Gungor G, Yapici B, Atalar B, Ozyar E.
  • Improvement of conformal arc plans by using deformable margin delineation method for stereotactic lung radiotherapy
    J Appl Clin Med Phys. 2017 Dec 7. doi:10.1002/acm2.12237 Güngör G, Demir M, Aydın G, Yapıcı B, Atalar B, Özyar E.
  • Comparison of 3D Conformal Arc and VMAT SBRT Plans for Lung Cancer SBRT Applications Based on Dose Limitations According to RTOG 0915 Protocol
    ACU Health Bil Derg 2017(3):146-149 Başlangıç B, Güngör G, Aydın G, Uluer M, Karademir M, Yapıcı B, Şahin B, Atalar B, Özyar E.
  • Rosenthal DI. Linguistic Validation of the Turkish Version of the M.D. Anderson Symptom Inventory – Head and Neck Cancer Module
    Balkan Med J. 2016 May;33(3):339-43 Gunn GB, Atalar B, Mendoza TR, Cleeland CS, Selek U, Ozyar E,
  • The Relationship Between FDG uptake of Primary Tumor and Lymph Node Metastasis on PET/CT in Cervical Cancer Patients
    ACU Health Bil Derg 2016 (3):129-133 Uğurluer G, Atalar B, Saran İkizler H.A, Sözer N, Kibar M, Serin M, Özyar E.
  • Dose-Response Modeling of the Visual Pathway Tolerance to Single-Fraction and Hypofractionated Stereotactic Radiosurgery
    Semin Radiat Oncol. 2016 Apr;26(2):97-104 Hiniker SM, Modlin LA, Choi CY, Atalar B, Seiger K, Binkley MS, Harris JP, Liao YJ, Fischbein N, Wang L, Ho A, Lo A, Chang SD, Harsh GR, Gibbs IC,
  • A Case of Glioblastoma Multiforme with Spinal Extension Metastasis
    Acibadem University Journal of Health Sciences 2014; 5(3): 251-253 Sahin B, Atalar B, Karaarslan E, Ozyar E.




×
Logo

29 hospitals and 15 medical centers in 5 countries.

About Us
Hospitals
Treatments
Doctors
Medical Technologies
Check Up Packages
Appointment
Blog
Health Library
Contact Us
Promotional
About Us

At ACIBADEM Healthcare Group, we are committed to healthcare excellence and providing world-class healthcare services to our patients. As a leader in international healthcare, we strive to deliver the highest quality of care and meet the needs of our diverse patient population.

Read More...
Appointment FormLive Support
Manage your privacy

We use technologies like cookies to store and/or access device information. We do this to improve browsing experience and to show (non-) personalized ads. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional
Always active
Preferences
Statistics